Insight, analysis & opinion from Joe Paduda

Jul
15

Hope-driven Hype

There’s a lot of hope – in my house just as in your’s – that we will have a safe, effective and durable COVID19 vaccine in 2020.

Hope is not a strategy, nor should it guide our personal or professional behavior and planning.

Consider this.

Vaccine development

  • the record for the fastest vaccine ever brought to market was 4 years for Merck’s mumps vaccine
  • We’ve been trying unsuccessfully to get an HIV vaccine since the 1980s
  • over the last quarter-century, a total of 7 vaccines for new pathogens have been successfully developed and rolled out globally.
  • From the CEO of Merck, the world’s largest vaccine company:
    There are a lot of examples of vaccines in the past that have stimulated the immune system, but ultimately didn’t confer protection. And unfortunately, there are some cases where it stimulated the immune system and not only it didn’t confer protection, but actually helped the virus invade the cell because it was incomplete in terms of its immunogenic properties. [emphasis added]

Merck CEO Kenneth Frazier

Vaccine delivery

COVID19 is a global pandemic; many countries have no where near the healthcare infrastructure the US has, are conducting far fewer tests, and don’t have the money to pay for expensive treatment or widespread immunization. Right now, even the US is in deep trouble with almost a quarter of the world’s recorded infections and over 130,000 deaths in six months – more than twice the number of Americans that died from opioid overdoses last year…

And;

  • some vaccines require boosters or are a two-shot series;
  • some must be given every year while others convey lifetime protection;
  • some require refrigeration and special handling;
  • this will likely require hundreds of millions of bottles, caps, syringes, needles or other delivery mechanisms;
  • all must be kept sterile until use;

Let us not forget there is a substantial number of people who reject immunizations for reasons of their own.

I’ll balance this with a note that the COVID19 vaccine effort is unprecedented; there are about 160 vaccine efforts now underway. Thousands of brilliant minds are using incredibly powerful computing systems to figure this out. They are using different delivery mechanisms, trying old vaccines, experimenting with RNA-based technology, working to stimulate the immune system all in an effort to stop or blunt the impact of COVID19 infections.

It’s possible we’ll have a proven vaccine proven to be safe, effective, and durable by the end of the year. It’s also unlikely.

Whenever it arrives, make sure you are alive and well enough to be vaccinated.

What does this mean for you?

Until then, wear the mask and don’t do stupid stuff.


Jul
14

COVID’s impact on work comp – Moody’s view

Moody’s report on the impact of COVID19 on workers’ compensation says stuff I agree with, namely:

Premium dollars will drop.

Rates will drop.

Claim counts will drop.

It also says profits will be pressured and future earnings reduced, asserting presumption and issues related to furloughed workers’ claims “could lead to…rising costs for workers’ compensation insurers.”

Whoa there cowboy…not so fast.

 

Reality is insurers are still collecting billions in premiums while claim counts and claim expenses are way down – and the cost of COVID claims is minimal. Unless premium income drops dramatically and/or COVID claim costs explode, work comp insurers’ profits are going to increase – not drop.

Here’s why.

As reported in my second survey of the Impact of COVID19 on Workers’ Compensation, claim counts plummeted in the first half of 2020 – but premiums did not.

Respondents indicated workers suffering relatively minor injuries are not reporting them. This isn’t surprising, as a) past research shows this happens when employment declines, because b) workers fear reporting a claim may affect their employment.

Next, workers with existing claims can’t/won’t access needed care. Yes, this likely extends disability duration, but it also reduces medical expense. Eventually medical expense may catch up – or not as there’s evidence some foregone treatment is not “made up.”

So, fewer claims and lower costs = higher profits for insurers.

Next – premium income.

Unlike auto insurers, there are no reports of workers’ comp insurers giving back or rebating premiums. Businesses that have closed permanently aren’t paying premiums, but most are still afloat and paying their bills.

Second, there’s no indication insurers have ramped up premium audits – which would result in credits or refunds to employers due to lower payroll. Unless and until those audits are done, employers that slashed their labor costs won’t get a refund.

So, premium income is declining somewhat – but expenses have dropped more and faster. Net – higher profits for insurers today.

Moody’s also opines that low interest rates and lower reserves will “pressure profits.”

First, interest rates have dropped since COVID came to our shores, but not by much, so I don’t see that the impact will be significant.

Second, insurers are still way over-reserved – and since actuaries base future claims on past experience, and we don’t have any past experience with pandemics, I find it hard to believe insurers will decide to slash reserves.

Third – and perhaps most important, medical inflation – or, more accurately, there isn’t medical inflation – which wasn’t addressed in Moody’s analysis. There is no evidence of significant medical cost inflation in workers’ comp. Yes, facility costs are problematic in some states, especially Florida.  This has been countered by a dramatic drop in drug costs, driven in large part by much lower opioid dispensing.

The net – medical inflation is in the low single digits – likely lower than most actuarial forecasts.

So, while there may be a little pressure on future profits, it won’t amount to much.

Finally, COVID and presumption.

The industry’s reaction to presumption law changes is reminiscent of the caterwauling over medical marijuana – lots of noise about not much. Reality is:

  1. Few COVID claims incur medical expenses.
  2. COVID claims aren’t expensive – on average COVID claims with medical expenses cost less than the typical lost time claim
  3. The impact of presumption changes has been minimal.

What does this mean for you?

Workers’ comp insurer profits aren’t likely to drop much – until a price war starts.

When (not if, but when) insurers start the inevitable war over market share, profits are going to drop – a lot.

Lastly, it does the industry no credit to continue keeping premiums high when employers and governments are getting crushed. It is time for insurers to stop the “yeah, but what if…” nonsense and do the right thing. 


Jul
10

Friday funday!

Ok, it’s been another terrific week…although my definition of “terrific” has changed a lot since January.

This being Friday, it’s time to lighten things up.

Today seems like…yesterday.

Therefore, it is time to look for a present for that special friend…

Some states are going back into lockdown, which is too bad cause you’re going to miss out on stuff like this.

SPORTS!

With worries about football season, baseball scheduled to play just 60 games, and the NBA playing in a bubble, it’s time to expand our horizons and consider other sports.

Baseball may not be it for this young player…

Looks like the SEC was practicing social distancing before we knew it was a thing.

This just in from Chicago…

That “other” football has to change too.

From an Eagles fan…

Finally, as a recovering Catholic, this brought back lots of memories.


Jul
9

myMatrixx released it’s annual Drug Trend Report yesterday; there’s a lot of good news – and a few trends that bear close attention.

The good stuff (lots more in the report itself)

  • drug costs per patient decreased by 2.4% despite a 1.9% increase in utilization
  • opioid cost per patient continued to drop, this time by 10.7%
  • comparing claims incurred in 2019 to those incurred in 2016 or earlier:
    • 45% fewer patients were prescribed opioids
    • the average days supply dropped by 2/3rds, from 28 to 9
    • the average morphine equivalent dose dropped by 40%

Stuff that demands your attention.

Many payers are working hard to close older claims. For claims older than about 8 years, pharmacy costs account for almost half of medical expenses. Obviously, ensuring the drugs prescribed and dispensed to long-term patients are still appropriate and are helping the patient recover is the first step in developing a plan to resolve these old – and very expensive – claims.

Specialty meds are becoming increasingly common – and increasingly costly, accounting for 8.8% of drug costs.

The bad stuff

Physician dispensers are the worst. They suck money out of employers and taxpayers, justifying their rampant profiteering by lying about maintaining patient access and improving care. 

Their latest scam is topicals. One out of every eight physician dispensed meds is a topical, but one out of every three dollars you pay for physician dispensed drugs is for a topical.

chart used by permission

One – methyl salicylate cream 25% – is available at retail pharmacies for about five bucks. Physician dispensers are getting $345.

I’ll save you the math – you are paying 69 times more than you should.

There’s a lot more detail in myMatrixx’ report – you can download it here.

What does this mean for you?

While payers and PBMs have made remarkable progress addressing opioids and controlling costs, much remains to be done:

  • keep the focus on long-term opioid patients
  • aggressively attack physician dispensing
  • if you don’t have a specialty med program, you’d best get one set up.(myMatrixx is an HSA consulting client)

Jul
8

Help me understand…

We are in the midst of a national pandemic, where:

Yes, Congress has appropriated funds to help cover the costs of COVID19 treatment, but those funds are likely woefully insufficient – especially now that the infection rate is exploding. Oh, and the Administration notes that its program to reimburse providers for treating uninsured COVID-19 patients is “subject to available funding.”

As hospital costs alone for these patients could be between $13.9 billion to $41.8 billion, that’s a huge caveat.

Into this disaster, the White House and Republicans are seeking to overturn the Affordable Care Act, which would:

  • end Medicaid expansion,
  • allow insurers to deny coverage,
    • based on pre-existing conditions,
    • for adult dependents up to age 26
  • allow insurers to charge whatever they want,
  • and allow insurers to limit payment or refuse coverage for any type of medical care they want.

So, 3 million of us now have been infected with COVID-19. Those unfortunates now have a pre-existing condition, which would – if the ACA is overturned – mean health insurers would be able to reject them and/or raise their premiums as much as the insurers want.

Let’s not forget many of the rest of us also have pre-existing conditions; personally I had cataract surgery years ago and several orthopedic injuries which would subject me to limits on coverage.

What’s even worse is the White House and Republicans have no alternative, no replacement plan, no solution or stopgap.

Nope, they want to blow up the current system and replace it with…nothing.

What does this mean for you?

Nothing good.

 


Jul
6

The stuff is hitting the fan

COVID19 is morphing, affecting different regions differently, infecting a different age cohort, and perhaps mutating.

What should workers’ comp service providers do?

  1.  Pay attention to the facts.
    Not the politicized nonsense from people who should know better, but the facts. Where is COVID19 spreading, what populations are being affected, what mitigation measures are and are not working.
  2. Pay attention to experts’ predictions – not politicians.
    Epidemiologists, Anthony Fauci, objective data scientists, and credible sites e.g.  COVID Forecast Hub. This last is particularly helpful as you can see predictions for infection rates and deaths based on aggregating carefully evaluated models.
  3. Understand that COVID’s impact will vary greatly by state, and even within individual states. For example, infection rates are exploding in many southeastern and southern states, while they’ve leveled off and are declining in most northeastern states.
    Death rates trail infection rates by 2-4 weeks; the COVID Forecast Hub’s excellent and fully transparent model will help you project what the next few weeks will bring in each state. (click on specific states for their data)

    For predictions of infection rates, go here to select individual states. The graph below compares New York and Texas…

    That’s great – and what do I do with it?

A few thoughts.

Compare different states to determine where your clients are going to need resources, help, staff – and what kinds. For states on the downslope (NY for an example), plan to reduce staffing while prepping those staff for work in states where infection rates are on the rise (e.g. TX).

Have your compliance staff research and prepare information for clients and your product development people. This a) helps your branding, and b) ensures your staff are working within state regulations.

Using infection predictions, track presumption laws and changes thereto, share that information with your clients, and develop services specific to each state.

Using death rate predictions as a proxy for severity and potential facility overload, devise ways to help find facilities for patients, perhaps even out of state. Contract with transportation entities to move patients when required.

I’m quite sure your front-line staff have a lot more and a lot better ideas than these; ask them for their thoughts on what they would have done differently

Finally, the elephant in the room. In what can only be described as a self-inflicted tragedy, idiots have politicized COVID19 and in so doing done incalculable harm.

COVID doesn’t care about your political ideology or party affiliation. Managing a business requires allegiance to facts based on data and decisions based on logic.

What does this mean for you?

Your competitors hope you listen to idiots.


Jun
30

The long haul

This isn’t going to be “over” for at least a year. Probably longer. Long enough that all of us must focus not on preparing for the end of the pandemic, but adapting to it and accepting that tomorrow will look just like today.

Allow me to make the case.

The only thing that will bring back “normal” life is “vaccinating” all of us. Period. That will happen – either by herd immunity (at least 2/3rds of us get infected and survive, so the virus can’t find enough carriers to keep the pandemic going) or by development, production, and use of a vaccine.

But…”Immunity” isn’t binary – think of it as a continuum rather than an on/off switch. Many vaccines reduce the severity of an illness rather than preventing it entirely. This means that COVID19 may well be with us for a long time, although its impact will be reduced.

Here are the issues. (caveat – there’s much we don’t know for certain, the following is culled from the most credible sources I could locate)

Stopping COVID19’s spread requires enough of us to have immunity that the virus can’t find hosts.  That immunity can come from antibodies created by our immune system reacting to an infection, or a vaccine. Antibodies are blood proteins produced in response to and counteracting a specific antigen – in this case COVID19.

Herd immunity

For myriad reasons, few countries have been able to stop COVID19’s spread. (New Zealand is an outlier, Taiwan and Vietnam have had notable success).  At the other end of the spectrum are Russia, the US and Brazil where the disease continues to spread rapidly.

There’s some research that suggests people who have had relatively mild cases of COVID19 don’t produce a lot of antibodies, thus may be vulnerable to future infections. Other research suggests antibodies may be pretty effective.

Another study found COVID19 patients’ antibody levels remained stable two months post-infection (that was when they were tested, it is possible levels remain high over a longer period).

Eventually, herd immunity will reduce the ability of COVID19 to spread, and likely reduce the severity of the illness – or prevent it entirely – among those who’ve been previously infected

Vaccines

There’s been much wildly optimistic and wholly unrealistic happy talk about a vaccine this fall. Is this possible?

Sure – about as possible that my beloved Chicago White Sox go undefeated and win the World Series.

  • The average development time for vaccines is about ten years. Lots of vaccines take even longer.
  • The fastest vaccine development  – for mumps – took four years (but that was way back in 1967, and we’ve got a lot smarter since then and technology is a gazillion times better) But, humans are still humans, and biology moves at its own pace, so there are inherent limits in the testing process
  • Despite 17 years of effort, we’ve never successfully developed a vaccine for a coronavirus.
  • If we don’t have a vaccine by this time next year, it won’t make much difference as COVID19’s spread will push us closer to herd immunity.
  • Once a vaccine is developed, hundreds of millions of doses and needles must be manufactured and an entire delivery infrastructure implemented. Good news here, the Feds are investing hundreds of millions in manufacturing potential vaccines, the idea being they will be ready to go IF they are found to be effective and safe.

If you want to track vaccine development, this link is pretty useful.

Takeaway

One of my favorite movie quotes is from Shawshank Redemption;  just after he learns his release from prison is not going to happen, Andy tells Red “I guess it comes down to a simple choice…get busy living, or get busy dying.”

Some will rail against the unfairness of it all, accuse others of all manner of sins, pine for the “old days”, and otherwise waste precious time and energy uselessly bemoaning our fate.

Which will keep them imprisoned behind walls of their own making. Others will accept the new reality, not resigning themselves to it but rather adapting, creating, building and eventually thriving.

 


Jun
29

COVID’s impact – Work comp payers and service companies weigh in

If you really want to know what COVID is doing to workers’ comp, you have to hear from those on the front lines.

35 workers’ comp insurers, TPAs, state funds, self-administered employers, and service companies gave me their views on the impact of COVID19 and employment on their businesses, claims counts, costs – and how they are adapting to a very different climate.Quick takeaways:

  • COVID claim costs are pretty low, with just a handful of claims exceeding a few hundred thousand dollars.
  • Shutdowns/Lockdowns = drop in payroll + business closures -> premium decreases, delayed RTW 
  • Respondents see total claim counts dropping 20% for 2020
  • Tele-everything is growing rapidly, but still has a long way to go
  • Many filed claims are not accepted because:
    • patient does not have a positive COVID test
    • patient is asymptomatic
    • Employers tend to give workers exposed to COVID19 two weeks of paid leave; they become WC claims if/when medical care is needed to treat COVID
  • Presumption is a concern, but less so than it was a couple months ago

Winners and losers

Service companies with the following attributes are generally doing much better than their counterparts:

  • no or low debt service cost and
  • on-shored business functions that
  • provide services typically used later in the claim’s life e.g. pharmacy.

Here are more details – and your free copy of the summary report is here.

A comprehensive version of the report including respondents’ detailed statements (respondents are not identified) and the accompanying raw data is available for purchase; contact jpadudaAThealthstrategyassocDOTcom. (substitute symbols for capitalized letters)

What does this mean for you?

For workers’ comp, the economic fallout from COVID is far more significant than COVID itself.


Jun
26

Masks and IWP gets hammered.

So, who knew masks could be so dangerous?

In our continued effort to keep us all honest about “science” and “research”, I have to weigh in on a recent piece wherein some folks seem to be concerned about mask wearing’s impact on a person’s health. The Risk & Insurance piece noted:

A study (italics added) conducted by PN Medical, and as reported in The New York Times, found that extended mask wearing could lead to improper breathing, which could result in possible negative side effects such as anxiety, headaches, increased heart rate, dizziness and fatigue.

This wasn’t a “study”; it was a “small investigative trial”. Details are here.

The person who described it is not a clinician.

There’s no information on how many subjects were involved, if there were any controls, the demographics of the test subjects, the methodology used, how the multi-site “trial” was conducted to ensure consistency, weather conditions, temperature and humidity, time of day, and the many other factors that could influence a person’s post-mask behavior and physiology.

The story goes on to describe all the bad stuff that “might” happen, all of which are assumptions based on assumptions based on what is most definitely not credible research.

Further, the story is based on another reporter’s failure to accurately describe the “small investigative trial;” a New York Times reporter at that.

It is entirely possible that masks cause some issues…but they’ve been in use for decades and this is the first report I’ve seen that there is any concern.

We need to do better, folks.

IWP gets hammered by Massachusetts’ Attorney General

Finally, IWP Pharmacy, long the bane of many adjusters, agreed to a Consent Decree that requires major changes at the Massachusetts-based mail order pharmacy. Mass AG Maura Healey announced that IWP will pay an $11 million settlement and make major changes to resolve:

allegations that it failed to implement adequate safeguards against unlawful and dangerous dispensing, resulting in the shipment of thousands of potentially illegitimate controlled substance prescriptions across the country.

In perhaps the most stunning example of spin I’ve yet seen, IWP’s statement doesn’t even mention the settlement… in a post entitled “IWP Expands Compliance Program” the multiple changes to staffing, operations, compliance, and sales were characterized as:

steps…developed in collaboration with the Attorney General of Massachusetts, as part of a recent review they undertook of past business practices.

The AG’s statement read in part:

“Injured Workers Pharmacy created an illegal operation that put dispensing speed and volume over patient and public safety…They dispensed thousands of prescriptions for dangerous drugs, including opioids like fentanyl, with a shocking lack of regard for whether those prescriptions were legitimate.”

What does this mean for you?

Question reporting and go to the primary source.

Check your files for IWP patients.


Jun
24

COVID catch-up

Apologies for the dearth of posts; vacation and slammed with client work.

Went bike-packing last week in the wilds of Pennsylvania and Maryland – had a great time off the grid, camping out, solving world problems around the fire at night.

Alas the world just created more…

Here’s a quick update on what I missed.

the great re-opening…or, what scares the bejesus out of me.

About 25 million people that can’t work remotely are at high risk if they contract COVID19. So, they a) have to go to work, b) many take public transportation, and c) are at high risk due to pre-ex conditions and poor health. This does not bode well for states experiencing increases in COVID19 cases.

Many states appear to have decided the healthcare implications of opening up outweigh the economic and societal costs of staying closed.

Florida is one such state:

This from JHU’s site.

Here’s a snapshot of positive tests, go here to get data on your state. The graphs show case counts from January thru yesterday; the greener the background the steeper the decline, the redder the steeper the increase.

Hospitals in seven states are in danger of being overwhelmed with new COVID-19 cases as fatalities increased yesterday for the first time since June 7. 33 states and territories have a higher rolling average of cases yesterday than they did last week.

Meanwhile the Federal government is scaling back its support for testing in 5 states.

Employment, payroll, and workers’ comp

As I noted in an earlier post, the biggest impact on workers’ comp will not come from COVID19 itself, but rather the dramatic drop in employment, business failures, and payroll.

According to NCCI, job losses peaked a couple months ago and employment has recovered somewhat…however there is wiiiiiiide variation across states, with some states as low as 8% unemployment and others up to 20%.

Remember the PPP dollars run out in a week, and when those $$ disappear, employers who had to keep workers on payroll to qualify for PPP won”t have to keep them “employed.” So, watch the unemployment numbers for early July closely.

Insiders are expecting a big increase in the number of corporate bankruptcies driven by way too much debt, changing buyer tastes, and of course COVID19. My take is COVID19 will accelerate the jump in bankruptcies, but the underlying drivers are the root cause; lots of debt works great…until it doesn’t.

The term for companies that are having big problems covering their interest expense is “Zombie”, signifying an entity that is dead but still stumbling around. About one out of five publicly-traded companies earns this sobriquet.

What does this mean for you?

Stay tuned to reports on unemployment and payroll changes in July. If the numbers aren’t good, the implications are broad and deep.


Joe Paduda is the principal of Health Strategy Associates

SUBSCRIBE BY EMAIL

SEARCH THIS SITE

A national consulting firm specializing in managed care for workers’ compensation, group health and auto, and health care cost containment. We serve insurers, employers and health care providers.

 

DISCLAIMER

© Joe Paduda 2024. We encourage links to any material on this page. Fair use excerpts of material written by Joe Paduda may be used with attribution to Joe Paduda, Managed Care Matters.

Note: Some material on this page may be excerpted from other sources. In such cases, copyright is retained by the respective authors of those sources.

ARCHIVES

Archives